Federal Regulations

After Congress passes a law, federal agencies write the detailed rules that make it real. Each rulemaking project gets a — and while a rule is proposed, anyone can comment on it.

12,931

rulemaking dockets

4,709

open for public comment

You can weigh in on these right now

Showing 30 of 12,931 dockets

Nonrulemaking

FDA

FDA-2026-H-5908

DAB Civil Money Penalty; Grassy Plain Vape & Smoke Route 7 LLC d/b/a Grassy Plain Smoke; CLOSED 7/22/2026

1 docNo comments

Rulemaking

IRS

Open for Comments

IRS-2026-0331

IRS Proposes Updated Rules for Tax-Exempt Bond Refunding and Rebate Procedures

3 docs6 comments

Comments due May 12, 2026

Nonrulemaking

NRC

NRC-2026-2344

NRC to Prepare Supplemental Environmental Review for Cooper Nuclear Station; Public Comments Open

3 docs1 comment

Nonrulemaking

NRC

NRC-2026-0265

NRC to Study Environmental Effects of Two Small Nuclear Reactors Proposed for Palisades, Michigan

3 docs6 comments

Rulemaking

FWS

Open for Comments

FWS-R8-ES-2025-0016

FWS to Review Seven Species for Endangered Status; Three Petitions Rejected

4 docs1 comment

Rulemaking

FWS

Open for Comments

FWS-R8-ES-2025-0017

FWS to Review Seven Species for Endangered Status; Three Petitions Rejected

5 docs2 comments

Rulemaking

FWS

Open for Comments

FWS-R8-ES-2025-0018

FWS to Review Seven Species for Endangered Status; Three Petitions Rejected

4 docs1 comment

Rulemaking

FWS

Open for Comments

FWS-R2-ES-2023-0136

Endangered and Threatened Wildlife and Plants; 90-Day Findings for ten Species; Southwest spring firefly

4 docs1 comment

Nonrulemaking

FWS

FWS-R7-ES-2025-1232

FWS proposes one-year permit for nonlethal disturbance of up to 34 sea otters during Angoon harbor work

9 docs3 comments

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-8053

Requests that the FDA amend and supplement the existing special control for tracheal prostheses under 21 CFR 878.3720 (Tracheal Prosthesis, Product Code NWA), so that it addresses a surface-quality risk specific to the way 3D printing is presently used to manufacture these devices

12 docsNo comments

Nonrulemaking

EPA

EPA-HQ-OPPT-2020-0490

Administrative Record AR-226: Per- and Polyfluoroalkyl Substances (PFAS)

3,754 docsNo comments

Nonrulemaking

FMCSA

Open for Comments

FMCSA-2026-1387

Trucking Company Seeks Permission to Log Short Local Moves as Yard Moves on ELDs

2 docs8 comments

Comments due Aug 18, 2026

Nonrulemaking

FMCSA

Open for Comments

FMCSA-2026-1882

MSC - In the Matter of AYS Transport LLC

3 docsNo comments

Nonrulemaking

SBA

SBA-2026-0166

Small Business Investment Company (“SBIC”) Program: SBA Model Form of Agreement for Limited Partnership SBICs

1 docNo comments

Rulemaking

FDA

Open for Comments

FDA-2015-N-0101

Safety and Effectiveness for Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use

1,453 docsNo comments

Comments due Oct 29, 2015

Nonrulemaking

FDA

FDA-2026-P-4232

FDA Says RASUVO Methotrexate Not Withdrawn for Safety or Effectiveness, Clearing Way for Generic Approval

4 docsNo comments

Nonrulemaking

DOT

Open for Comments

DOT-OST-2026-1486

Jet Mach Mexico, S.A. de C.V. - Exemption - U.S./Mexico Charter Air Transportation

2 docsNo comments

Nonrulemaking

FAA

FAA-2026-4889

Big Island Jet Center v. Hawaii Department of Transportation Airports Division (16-26-15)

8 docsNo comments

Nonrulemaking

DOT

Open for Comments

DOT-OST-2024-0070

Eximflight, S.A. de C.V. - Exemption - U.S./Mexico Charter Air Transportation

5 docsNo comments

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-1300

Request that the FDA declare that the BELSOMRA® (Suvorexant) Tablets 5 mg, 10 mg, 15 mg and 20 mg, approved under NDA # 204569 is suitable for submission as an abbreviated new drug application (ANDA)

9 docsNo comments

Rulemaking

FDA

Open for Comments

FDA-2025-N-6075

FDA proposes allowing single registration for drug makers with multiple sites and tightening foreign listing rules

28 docsNo comments

Comments due Sep 12, 2026

Nonrulemaking

DOT

Open for Comments

DOT-OST-2026-1355

Aviones y Helocopteros Ejecutivos, S.A. de C.V. d/b/a Ahesa - Exemption - U.S./Mexico Charter Air Transportation

2 docsNo comments

Nonrulemaking

FDA

FDA-2026-H-7907

DAB Civil Money Penalty; Chocolate Deli & Grocery, Inc. d/b/a Deli Grocery

1 docNo comments

Nonrulemaking

DOT

Open for Comments

DOT-OST-2026-2311

Aerolíneas de Morelia, S.A. de C.V. - Exemption - U.S./Mexcio Charter Air Transportation

2 docsNo comments

Nonrulemaking

DOT

Open for Comments

DOT-OST-2016-0176

Saudi Arabian Airlines Corporation - Amended Foreign Air Carrier Permit - U.S.-Saudi Arabia Open Skies Agreement

10 docsNo comments

Nonrulemaking

FDA

FDA-2011-N-0060

Positron Emission Tomography; Notice of Public Meeting

2 docs1 comment

Nonrulemaking

FAR

FAR-2026-0166

Agencies Seek Public Comment to Extend Paperwork Rules for Federal Contracts

1 docNo comments

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-7530

Requests that FDA determine that the proposed new strength, Ertapenem for Injection, 500 mg/vial, developed by Qilu Antibiotics Pharmaceutical Co., Ltd., is suitable for submission in an Abbreviated New Drug Application (ANDA)

6 docsNo comments

Rulemaking

FDA

Open for Comments

FDA-1995-S-0036

Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24

239 docsNo comments

Comments due Jul 15, 2022

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-8054

Requesting that the FDA recognize humans as gods, approve pharmaceuticals or technologies that enable humans to attain god-like abilities, and issue any necessary regulations or orders to facilitate this recognition and approval

2 docsNo comments